| __timestamp | Amneal Pharmaceuticals, Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 24890000000 |
| Thursday, January 1, 2015 | 866280000 | 32639000000 |
| Friday, January 1, 2016 | 1018225000 | 30390000000 |
| Sunday, January 1, 2017 | 1033654000 | 26107000000 |
| Monday, January 1, 2018 | 1662991000 | 22127000000 |
| Tuesday, January 1, 2019 | 1626373000 | 22449000000 |
| Wednesday, January 1, 2020 | 1992523000 | 24689000000 |
| Friday, January 1, 2021 | 2093669000 | 27305000000 |
| Saturday, January 1, 2022 | 2212304000 | 27281000000 |
| Sunday, January 1, 2023 | 2393607000 | 27116000000 |
| Monday, January 1, 2024 | 28754000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success. This analysis compares the annual revenue trends of Gilead Sciences, Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023.
Gilead Sciences, a leader in antiviral drugs, consistently outperformed Amneal Pharmaceuticals, a generic drug manufacturer, in terms of revenue. In 2015, Gilead's revenue peaked at approximately $32.6 billion, marking a 31% increase from 2014. However, by 2018, it experienced a decline to around $22.1 billion, a 32% drop from its peak. Meanwhile, Amneal's revenue showed a steady upward trend, growing by 205% from $785 million in 2014 to nearly $2.4 billion in 2023.
This data highlights the contrasting revenue trajectories of these two pharmaceutical giants, reflecting their strategic focuses and market positions.
Who Generates More Revenue? Eli Lilly and Company or Gilead Sciences, Inc.
Novo Nordisk A/S or Gilead Sciences, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Novartis AG or Gilead Sciences, Inc.?
Gilead Sciences, Inc. vs Genmab A/S: Examining Key Revenue Metrics
Revenue Showdown: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Revenue Insights: Gilead Sciences, Inc. and Novavax, Inc. Performance Compared
Revenue Insights: Gilead Sciences, Inc. and Viridian Therapeutics, Inc. Performance Compared
Cytokinetics, Incorporated and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Telix Pharmaceuticals Limited vs Amneal Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Annual Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.